Search results
Results From The WOW.Com Content Network
Alanine transaminase (ALT), also known as alanine aminotransferase (ALT or ALAT), formerly serum glutamate-pyruvate transaminase (GPT) or serum glutamic-pyruvic transaminase (SGPT), is a transaminase enzyme (EC 2.6.1.2) that was first characterized in the mid-1950s by Arthur Karmen and colleagues. [1]
In alcoholic liver disease, the mean ratio is 1.45, and mean ratio is 1.33 in post necrotic liver cirrhosis. Ratio is greater than 1.17 in viral cirrhosis, greater than 2.0 in alcoholic hepatitis, and 0.9 in non-alcoholic hepatitis. Ratio is greater than 4.5 in Wilson disease or hyperthyroidism. [6]
The INR is a corrected ratio of a patient's PT to normal Activated partial thromboplastin time (APTT) 18, [15] 30 [5] [18] 28, [15] 42, [5] 45 [18] s: Thrombin clotting time (TCT) 11: 18: s: Fibrinogen: 1.7, [15] 2.0 [5] 3.6, [5] 4.2 [15] g/L: Antithrombin: 0.80 [5] 1.2 [5] kIU/L: 0.15, [151] 0.17 [152] 0.2, [151] 0.39 [152] mg/mL Bleeding time ...
In the same study, it showed that Bg7S is the protein globulin that is soluble in certain high ionic strength of a salt solution that should have a high isoelectric point as well which should be around 9.05 to 9.26 pI. This type of globulin is found in many different plants such as tomatoes, corn, wheat, and carrots.
Hypercalcemia, also spelled hypercalcaemia, is a high calcium (Ca 2+) level in the blood serum. [1] [3] The normal range for total calcium is 2.1–2.6 mmol/L (8.8–10.7 mg/dL, 4.3–5.2 mEq/L), with levels greater than 2.6 mmol/L defined as hypercalcemia. [1] [2] [4] Those with a mild increase that has developed slowly typically have no ...
The c inj value is calculated as ratio of two independent measurements: the injected radioactivity (injected dose, ID) and the body weight (BW) of the subject. The ID can be estimated e.g. as difference in the radioactivity of the syringe before and after injection, if deemed necessary with correction for physical decay between each of those measurements and the time of injection.
2,6-DAP was used to treat leukemia since as early as 1951. [13] It is known to arrest progression of cell cycle in mouse leukemia cells by 1989. [ 14 ] Cancer cells are known to become resistant to DAP by losing their adenine phosphoribosyltransferase (APRT) function, [ 15 ] a process shared with E. coli .
An inverted CD4 + /CD8 + ratio (namely, less than 1/1) indicates an impaired immune system. [3] [4] [5] Conversely, an increased CD4 + /CD8 + ratio corresponds to increased immune function. [6] Obesity and dysregulated lipid metabolism in the liver leads to loss of CD4 +, but not CD8 + cells, contributing to the induction of liver cancer. [7]